Last reviewed · How we verify
NCT06876727: EVAR_DAPT_SAPT
Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair
trial in Abdominal Aortic Aneurysms (AAA) in 8,325 participants. Completed in 30 September 2023.
30 September 2023
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 8,325 |
| Start date | 1 January 2003 |
| Primary completion | 30 September 2023 |
| Estimated completion | 30 September 2023 |
Conditions studied
- Abdominal Aortic Aneurysms (AAA) — all drugs for Abdominal Aortic Aneurysms (AAA) →
- Endovascular Aneurysm Repair (EVAR) — all drugs for Endovascular Aneurysm Repair (EVAR) →
Sponsor
Samsung Medical Center
Who can join
18 and older, any sex, with Abdominal Aortic Aneurysms (AAA) or Endovascular Aneurysm Repair (EVAR). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was a target trial emulation using the National Health Claims database established by the Korean National Health Insurance Service (K-NHIS). 8,325 patients were included.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair: A Target Trial Emulation.
Choi KH, Kang D, Nam J, Park TK, et al · · 2025 · PMID 41065286 · DOI 10.1161/jaha.125.044102
Verify or expand the search:
- PubMed search for NCT06876727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Aortic Aneurysms (AAA)
Currently open trials in the same condition.
- NCT07026877 — Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA · NA · recruiting
- NCT06884397 — Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery · recruiting
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06876727 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 14 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06876727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing